OdalizAbreu-LanfrancoMDFACP

PubMed

• Genitourinary Tract Infections.
  Lanfranco OA, Alangaden GJ> ;Microbiology spectrum.
• MRSA guidelines: a matter of time.
  Levine DP, Lanfranco OA> ;Expert review of anti-infective therapy.
• Contemporary review of drug-induced pancreatitis: A different perspective.
  Hung WY, Abreu Lanfranco O> ;World journal of gastrointestinal pathophysiology.
• Ambulatory Quinolone Prescribing: Moving From Opportunity to Implementation.
  Mercuro NJ, Kenney RM, Abreu-Lanfranco O, Davis SL> ;Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
• Impact and Limitations of the 2015 National Health and Safety Network Case Definition on Catheter-Associated Urinary Tract Infection Rates.
  Bardossy AC, Jayaprakash R, Alangaden AC, Starr P, Abreu-Lanfranco O, Reyes K, Zervos MJ, Alangaden GJ> ;Infection control and hospital epidemiology. 2016-11-24
• Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10.
  Pogue, J. M.,Marchaim, D.,Abreu-Lanfranco, O.,Sunkara, B.,Mynatt, R. P.,Zhao, J. J.,Bheemreddy, S.,Hayakawa, K.,Martin, E. T.,Dhar, S.,Kaye, K. S.,Lephart, P. R.> ;J. Antibiot.. 2013 May 29
• A Trial of Discontinuation of Empiric Vancomycin Therapy in Patients with Suspected Methicillin-Resistant Staphylococcus aureus Health Care-Associated Pneumonia.
  Boyce, J. M.,Pop, O. F.,Abreu-Lanfranco, O.,Hung, W. Y.,Fisher, A.,Karjoo, A.,Thompson, B.,Protopapas, Z.> ;Antimicrob. Agents Chemother.. 2013 Mar
• The carbapenem-resistant Enterobacteriaceae score: a bedside score to rule out infection with carbapenem-resistant Enterobacteriaceae among hospitalized patients.
  Martin ET, Tansek R, Collins V, Hayakawa K, Abreu-Lanfranco O, Chopra T, Lephart PR, Pogue JM, Kaye KS, Marchaim D> ;American journal of infection control. 2012-08-30
• Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections.
  Ku K, Pogue JM, Moshos J, Bheemreddy S, Wang Y, Bhargava A, Campbell M, Khandker N, Lephart PR, Chopra T, Hayakawa K, Martin ET, Abreu-Lanfranco O, Dhar S, Kaye KS, Ma...> ;American journal of infection control. 2012-03-21
• Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae.
  Collins VL, Marchaim D, Pogue JM, Moshos J, Bheemreddy S, Sunkara B, Shallal A, Chugh N, Eiseler S, Bhargava P, Blunden C, Lephart PR, Memon BI, Hayakawa K, Abreu-Lanf...> ;Antimicrobial agents and chemotherapy. 2012-01-30
• Hospital bath basins are frequently contaminated with multidrug-resistant human pathogens.
  Marchaim D, Taylor AR, Hayakawa K, Bheemreddy S, Sunkara B, Moshos J, Chopra T, Abreu-Lanfranco O, Martin ET, Pogue JM, Lephart PR, Panda S, Dhar S, Kaye KS> ;American journal of infection control. 2011-12-16
• Prevention of liver fibrosis by the purinoceptor antagonist pyridoxal-phosphate-6-azophenyl-2'',4''-disulfonate (PPADS).
  Dranoff, J. A., Kruglov, E. A., Abreu-Lanfranco, O., Nguyen, T., Arora, G., Aurora, G., Jain, D.> ;In Vivo. 2008 Jan 24
• Join now to see all